ENANTA PHARMACEUTICALS INC financial data

Symbol
ENTA on Nasdaq
Location
Watertown, MA
Fiscal year end
30 September
Latest financial report
10-Q - Q4 2025 - 11 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 473% % -14%
Debt-to-equity 239% % 35%
Return On Equity -79% % -4%
Return On Assets -23% % 15%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 29,019,344 shares 36%
Common Stock, Shares, Outstanding 29,019,000 shares 36%
Entity Public Float $110,592,792 USD -68%
Common Stock, Value, Issued $290,000 USD 36%
Weighted Average Number of Shares Outstanding, Basic 28,748,000 shares 35%
Weighted Average Number of Shares Outstanding, Diluted 28,748,000 shares 35%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $66,980,000 USD 0.58%
Research and Development Expense $99,943,000 USD -19%
General and Administrative Expense $40,096,000 USD -26%
Costs and Expenses $140,039,000 USD -21%
Operating Income (Loss) $73,059,000 USD 34%
Nonoperating Income (Expense) $302,000 USD -92%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $72,757,000 USD 32%
Income Tax Expense (Benefit) $1,220,000 USD 21%
Net Income (Loss) Attributable to Parent $71,537,000 USD 32%
Earnings Per Share, Basic -3.21 USD/shares 35%
Earnings Per Share, Diluted -3.21 USD/shares 35%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $37,437,000 USD -56%
Accounts Receivable, after Allowance for Credit Loss, Current $8,493,000 USD 10%
Assets, Current $198,684,000 USD -26%
Property, Plant and Equipment, Net $34,308,000 USD -8.2%
Operating Lease, Right-of-Use Asset $37,003,000 USD -6.7%
Other Assets, Noncurrent $93,000 USD -1.1%
Assets $329,503,000 USD -5.5%
Accounts Payable, Current $1,885,000 USD -60%
Employee-related Liabilities, Current $2,401,000 USD -41%
Accrued Liabilities, Current $7,575,000 USD -28%
Liabilities, Current $44,728,000 USD -8.8%
Operating Lease, Liability, Noncurrent $53,782,000 USD -4.7%
Other Liabilities, Noncurrent $269,000 USD 14%
Liabilities $202,912,000 USD -14%
Accumulated Other Comprehensive Income (Loss), Net of Tax $329,000 USD -1034%
Retained Earnings (Accumulated Deficit) $416,867,000 USD -21%
Stockholders' Equity Attributable to Parent $126,591,000 USD 13%
Liabilities and Equity $329,503,000 USD -5.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $11,699,000 USD 30%
Net Cash Provided by (Used in) Financing Activities $64,136,000 USD
Net Cash Provided by (Used in) Investing Activities $47,298,000 USD -169%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 29,019,000 shares 36%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $5,139,000 USD -89%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,379,000 USD -21%
Deferred Tax Assets, Valuation Allowance $142,233,000 USD 12%
Deferred Tax Assets, Gross $154,217,000 USD 9.1%
Operating Lease, Liability $57,903,000 USD 4.4%
Payments to Acquire Property, Plant, and Equipment $143,000 USD -98%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $71,837,000 USD 31%
Lessee, Operating Lease, Liability, to be Paid $86,018,000 USD -9.2%
Property, Plant and Equipment, Gross $59,200,000 USD 2.5%
Operating Lease, Liability, Current $3,287,000 USD 227%
Lessee, Operating Lease, Liability, to be Paid, Year Two $8,721,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $8,467,000 USD -2.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.088 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $27,785,000 USD -16%
Lessee, Operating Lease, Liability, to be Paid, Year Three $8,983,000 USD 3%
Deferred Tax Assets, Operating Loss Carryforwards $14,782,000 USD 103%
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $892,000 USD -1.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four $9,252,000 USD 3%
Deferred Tax Assets, Net of Valuation Allowance $11,984,000 USD -15%
Share-based Payment Arrangement, Expense $16,709,000 USD -31%
Interest Expense $2,355,000 USD 18%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%